Objective: Obstructive sleep apnea-hypopnea syndrome (OSA) is a disease of obstructive apnea or hypopnea caused by a repeated partial or complete collapse of the upper airway during sleep. The inspiratory part of the ...Objective: Obstructive sleep apnea-hypopnea syndrome (OSA) is a disease of obstructive apnea or hypopnea caused by a repeated partial or complete collapse of the upper airway during sleep. The inspiratory part of the flow-volume curve (F-V curve) can be used as an auxiliary means to evaluate upper airway obstruction in adults. This study is to evaluate the ability of the F-V curve to predict the OSA and explore inspiratory indicators related to airway obstruction during sleep. Methods: There were 332 patients included in this cross-sectional study, who were accompanied by snoring, daytime sleepiness and other symptoms, with suspicion of OSA. According to the nocturnal polysomnography, the subjects were distributed into mild to moderate OSA group, severe OSA group and non-OSA group. A pulmonary function test was used to collect the subjects’ spirometry and F-V curves. Results: There was no significant difference in a variety of indices derived from the F-V curve between OSA and normal subjects, including 25% inspiratory flow rate, middle inspiratory flow rate, 75% inspiratory flow rate, peak flow rate, and forced inspiratory flow rate in the first second. The pulmonary function parameters were significantly correlated with the weight, age and sex of the subjects. Conclusion: These findings suggest that the inspiratory curve of pulmonary function cannot evaluate the upper airway abnormalities in patients with obstructive apnea-hypopnea syndrome.展开更多
目的:探讨阻塞性睡眠呼吸暂停(obstructive sleep apnea,OSA)与认知功能、抑郁及焦虑的关系,并分析影响认知功能的因素。方法:纳入2022年1月至2023年6月,安徽医科大学第三附属医院滨湖院区行多导睡眠监测(polysomnography,PSG)的患者共...目的:探讨阻塞性睡眠呼吸暂停(obstructive sleep apnea,OSA)与认知功能、抑郁及焦虑的关系,并分析影响认知功能的因素。方法:纳入2022年1月至2023年6月,安徽医科大学第三附属医院滨湖院区行多导睡眠监测(polysomnography,PSG)的患者共102例,根据PSG结果分为无或轻度OSA组及中、重度OSA组,完善蒙特利尔认知评估量表(MoCA-Beijing)、Stroop色词试验(stroop Color and Word Tset,SCWT)、数字广度测验(digit Span Test,DST)、抑郁自评量表(self-rating depression scale,SDS)、焦虑自评量表(self-rating anxiety scale,SAS),记录各量表的评分值,并分析差异性及相关性等。结果:中-重度OSA组的颈围、BMI、SCWT-A、B、C耗时数、SIE、SAS、SDS显著高于无-轻度OSA组,MoCA视空间与执行能力、记忆、语言、抽象、延迟回忆、定向及MoCA总分、最低血氧饱和度(LSaO_(2))、平均血氧饱和度、DST-b、DST-f得分显著低于无-轻度OSA组(P均<0.05)。颈围、AHI、SAS与MoCA评分相关(OR=1.401,95%CI:1.702~1.803;OR=1.028,95%CI:1.007~1.050;OR=1.070,95%CI:0.991~1.155,P均<0.05),AHI与SDS、SAS评分相关(OR=1.001,95%CI:0.979~.025,P=0.003)。结论:中-重度OSA患者常合并认知功能障碍及抑郁、焦虑相关情绪问题,与AHI、LSaO_(2)、平均血氧饱和度指标密切相关,OSA合并焦虑与认知功能障碍具有显著相关性。展开更多
To investigate the possible correlation between obstructive sleep apnea(OSA) and central retinal vein occlusion(CRVO). Thirty consecutive patients with a recent(<3 mo)CRVO and an age-and sex-matched group of 30 con...To investigate the possible correlation between obstructive sleep apnea(OSA) and central retinal vein occlusion(CRVO). Thirty consecutive patients with a recent(<3 mo)CRVO and an age-and sex-matched group of 30 control subjects were recruited. All subjects underwent full-night polysomnography to measure apnea-hypopnea index(AHI)and oxygen desaturation index(ODI). The average AHI and ODI were significantly higher in CRVO patients(AHI:13.86±8.63, ODI: 9.21±4.47) than in control subjects(AHI:8.51±6.36, ODI: 5.87±3.18;P=0.008 and 0.001 respectively).Additionally, the AHI was positively correlated with body mass index(BMI;r=0.476, P=0.017) and ODI(r=0.921,P<0.01) in both CRVO and control subjects. According to AHI scores, twenty-two(73.33%) CRVO patients had OSA and 12(40.00%) control subjects had OSA, a difference that was statistically significant(P=0.019). OSA may be a risk factor for or a trigger of CRVO development.展开更多
It is known that acute or chronic heart failure can develop in patients with grave sleep apnea syndrome (SAS), and known to have the social problem including an accident and the decrease of the labor will. Several med...It is known that acute or chronic heart failure can develop in patients with grave sleep apnea syndrome (SAS), and known to have the social problem including an accident and the decrease of the labor will. Several medical treatments are now available for SAS. We considered problems of the treatment based on the practice situation of our department about the present conditions and subsequent treatment. The subjects consisted of 306 patients. We measured Epworth Sleepiness Scale (ESS) and apnea hypopnea index (AHI) after polysomnography in all patients at the first time and 6 months later. So, it was found that AHI and ESS decreased when we could be treated in the SAS patients appropriately. It was confirmed that the choice of the appropriate regimen was important.展开更多
<b>Background:</b><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:V...<b>Background:</b><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"> Obstructive sleep apnea syndrome (OSAS) may promote</span></span></span></span><span><span><span><span style="font-family:;" "=""><span style="font-family:Verdana;"> hyperglycemia, insulin resistance, and hypertension (HTN). </span><b><span style="font-family:Verdana;">Purpose:</span></b><span style="font-family:Verdana;"> To evaluate if there is a relationship between the severity of OSA and the severity of type 2 diabetes mellitus (T2DM) and HTN in our patients, aiming to understand and optimize the control for comorbidities. </span><b><span style="font-family:Verdana;">Materials and Methods:</span></b><span style="font-family:Verdana;"> Patients referred for polysomnography (PSG) were retrospectively recruited during the period from October 2017 to August 2020. A STOP-BANG questionnaire formed eight questions was used to assess the risk of OSAS. We divided the patients </span></span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">in</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">to two group</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">s</span></span></span></span><span><span><span><span style="font-family:;" "=""><span style="font-family:Verdana;">;group 1, who have snoring without T2DM, and group 2, who have snoring with T2DM. PSG was completed for all subjects and data were collected for each patient including apnoea hypopnea index </span><span><span style="font-family:Verdana;">(AHI), mean arterial oxygen saturation (SaO</span><sub><span style="font-family:Verdana;">2</span></sub><span style="font-family:Verdana;">), and Nadir SaO</span><sub><span style="font-family:Verdana;">2</span></sub><span style="font-family:Verdana;"> recorded</span></span><span style="font-family:Verdana;"> during PSG. Anthropometric data, medical history, and medications for T2DM (for group 2) and HTN and HbA1c were collected (for group 2). AHI was used to evaluate the severity of OSA and its relation to T2DM and HTN. </span><b><span style="font-family:Verdana;">Results:</span></b><span style="font-family:Verdana;"> The study included 300 patients who met the inclusion criteria with</span><span style="color:red;"> </span><span style="font-family:Verdana;">mean age </span></span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">of </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">49.9 ± 13.6 years. </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">The </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">majority of subjects (56.3%) were males and the mean body mass index (BMI) was 38.0 ± 8.4 kg/m</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><sup><span style="font-family:Verdana;">2</span></sup></span></span></span><span><span><span><span style="font-family:;" "=""><span style="font-family:Verdana;">. Forty-two percent had HTN and 32.7% had T2DM. OSA was diagnosed in 209 patients (69.7%). OSA was more detected among those with increased age, increased BMI, and those with HTN and T2DM. The severity of both HTN and T2DM was significantly higher among patients with OSA. </span><b><span style="font-family:Verdana;">Conclusions:</span></b><span style="font-family:Verdana;"> There is a relation between OSA and T2DM and HTN. </span></span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">The </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">risk of OSA is higher among patients with uncontrolled T2DM and HTN. OSA should be suspected in subjects with obesity, especially with uncontrolled HTN and T2DM.</span></span></span></span>展开更多
文摘Objective: Obstructive sleep apnea-hypopnea syndrome (OSA) is a disease of obstructive apnea or hypopnea caused by a repeated partial or complete collapse of the upper airway during sleep. The inspiratory part of the flow-volume curve (F-V curve) can be used as an auxiliary means to evaluate upper airway obstruction in adults. This study is to evaluate the ability of the F-V curve to predict the OSA and explore inspiratory indicators related to airway obstruction during sleep. Methods: There were 332 patients included in this cross-sectional study, who were accompanied by snoring, daytime sleepiness and other symptoms, with suspicion of OSA. According to the nocturnal polysomnography, the subjects were distributed into mild to moderate OSA group, severe OSA group and non-OSA group. A pulmonary function test was used to collect the subjects’ spirometry and F-V curves. Results: There was no significant difference in a variety of indices derived from the F-V curve between OSA and normal subjects, including 25% inspiratory flow rate, middle inspiratory flow rate, 75% inspiratory flow rate, peak flow rate, and forced inspiratory flow rate in the first second. The pulmonary function parameters were significantly correlated with the weight, age and sex of the subjects. Conclusion: These findings suggest that the inspiratory curve of pulmonary function cannot evaluate the upper airway abnormalities in patients with obstructive apnea-hypopnea syndrome.
文摘目的:探讨阻塞性睡眠呼吸暂停(obstructive sleep apnea,OSA)与认知功能、抑郁及焦虑的关系,并分析影响认知功能的因素。方法:纳入2022年1月至2023年6月,安徽医科大学第三附属医院滨湖院区行多导睡眠监测(polysomnography,PSG)的患者共102例,根据PSG结果分为无或轻度OSA组及中、重度OSA组,完善蒙特利尔认知评估量表(MoCA-Beijing)、Stroop色词试验(stroop Color and Word Tset,SCWT)、数字广度测验(digit Span Test,DST)、抑郁自评量表(self-rating depression scale,SDS)、焦虑自评量表(self-rating anxiety scale,SAS),记录各量表的评分值,并分析差异性及相关性等。结果:中-重度OSA组的颈围、BMI、SCWT-A、B、C耗时数、SIE、SAS、SDS显著高于无-轻度OSA组,MoCA视空间与执行能力、记忆、语言、抽象、延迟回忆、定向及MoCA总分、最低血氧饱和度(LSaO_(2))、平均血氧饱和度、DST-b、DST-f得分显著低于无-轻度OSA组(P均<0.05)。颈围、AHI、SAS与MoCA评分相关(OR=1.401,95%CI:1.702~1.803;OR=1.028,95%CI:1.007~1.050;OR=1.070,95%CI:0.991~1.155,P均<0.05),AHI与SDS、SAS评分相关(OR=1.001,95%CI:0.979~.025,P=0.003)。结论:中-重度OSA患者常合并认知功能障碍及抑郁、焦虑相关情绪问题,与AHI、LSaO_(2)、平均血氧饱和度指标密切相关,OSA合并焦虑与认知功能障碍具有显著相关性。
基金Supported by Planned Science and Technology Project of Xi’an City, China [No.2017116SF/YX010(9)]
文摘To investigate the possible correlation between obstructive sleep apnea(OSA) and central retinal vein occlusion(CRVO). Thirty consecutive patients with a recent(<3 mo)CRVO and an age-and sex-matched group of 30 control subjects were recruited. All subjects underwent full-night polysomnography to measure apnea-hypopnea index(AHI)and oxygen desaturation index(ODI). The average AHI and ODI were significantly higher in CRVO patients(AHI:13.86±8.63, ODI: 9.21±4.47) than in control subjects(AHI:8.51±6.36, ODI: 5.87±3.18;P=0.008 and 0.001 respectively).Additionally, the AHI was positively correlated with body mass index(BMI;r=0.476, P=0.017) and ODI(r=0.921,P<0.01) in both CRVO and control subjects. According to AHI scores, twenty-two(73.33%) CRVO patients had OSA and 12(40.00%) control subjects had OSA, a difference that was statistically significant(P=0.019). OSA may be a risk factor for or a trigger of CRVO development.
文摘It is known that acute or chronic heart failure can develop in patients with grave sleep apnea syndrome (SAS), and known to have the social problem including an accident and the decrease of the labor will. Several medical treatments are now available for SAS. We considered problems of the treatment based on the practice situation of our department about the present conditions and subsequent treatment. The subjects consisted of 306 patients. We measured Epworth Sleepiness Scale (ESS) and apnea hypopnea index (AHI) after polysomnography in all patients at the first time and 6 months later. So, it was found that AHI and ESS decreased when we could be treated in the SAS patients appropriately. It was confirmed that the choice of the appropriate regimen was important.
文摘<b>Background:</b><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"> Obstructive sleep apnea syndrome (OSAS) may promote</span></span></span></span><span><span><span><span style="font-family:;" "=""><span style="font-family:Verdana;"> hyperglycemia, insulin resistance, and hypertension (HTN). </span><b><span style="font-family:Verdana;">Purpose:</span></b><span style="font-family:Verdana;"> To evaluate if there is a relationship between the severity of OSA and the severity of type 2 diabetes mellitus (T2DM) and HTN in our patients, aiming to understand and optimize the control for comorbidities. </span><b><span style="font-family:Verdana;">Materials and Methods:</span></b><span style="font-family:Verdana;"> Patients referred for polysomnography (PSG) were retrospectively recruited during the period from October 2017 to August 2020. A STOP-BANG questionnaire formed eight questions was used to assess the risk of OSAS. We divided the patients </span></span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">in</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">to two group</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">s</span></span></span></span><span><span><span><span style="font-family:;" "=""><span style="font-family:Verdana;">;group 1, who have snoring without T2DM, and group 2, who have snoring with T2DM. PSG was completed for all subjects and data were collected for each patient including apnoea hypopnea index </span><span><span style="font-family:Verdana;">(AHI), mean arterial oxygen saturation (SaO</span><sub><span style="font-family:Verdana;">2</span></sub><span style="font-family:Verdana;">), and Nadir SaO</span><sub><span style="font-family:Verdana;">2</span></sub><span style="font-family:Verdana;"> recorded</span></span><span style="font-family:Verdana;"> during PSG. Anthropometric data, medical history, and medications for T2DM (for group 2) and HTN and HbA1c were collected (for group 2). AHI was used to evaluate the severity of OSA and its relation to T2DM and HTN. </span><b><span style="font-family:Verdana;">Results:</span></b><span style="font-family:Verdana;"> The study included 300 patients who met the inclusion criteria with</span><span style="color:red;"> </span><span style="font-family:Verdana;">mean age </span></span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">of </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">49.9 ± 13.6 years. </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">The </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">majority of subjects (56.3%) were males and the mean body mass index (BMI) was 38.0 ± 8.4 kg/m</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><sup><span style="font-family:Verdana;">2</span></sup></span></span></span><span><span><span><span style="font-family:;" "=""><span style="font-family:Verdana;">. Forty-two percent had HTN and 32.7% had T2DM. OSA was diagnosed in 209 patients (69.7%). OSA was more detected among those with increased age, increased BMI, and those with HTN and T2DM. The severity of both HTN and T2DM was significantly higher among patients with OSA. </span><b><span style="font-family:Verdana;">Conclusions:</span></b><span style="font-family:Verdana;"> There is a relation between OSA and T2DM and HTN. </span></span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">The </span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">risk of OSA is higher among patients with uncontrolled T2DM and HTN. OSA should be suspected in subjects with obesity, especially with uncontrolled HTN and T2DM.</span></span></span></span>